Synapse - Sasan Karimi

Search Within

Sasan Karimi

Results (115)

Characterizing hypervascular and hypovascular metastases and normal bone marrow of the spine using dynamic contrast-enhanced MR imaging

Journal Article

Khadem, N. R.; Karimi, S.; Peck, K. K. ; Yamada, Y.; Lis, E.; Lyo, J.; Bilsky, M.; Vargas, H. A.; Holodny, A. I.
American Journal of Neuroradiology (2012)

Fulltext@MSK | Save

Dynamic contrast enhanced magnetic resonance imaging-based assessment of tumor response to high-dose spine stereotactic radiosurgery

Meeting Abstract

Yamada, Y.; Karimi, S.; Peck, K.; Lis, E.; Lyo, J.; Bilsky, M.; Cox, B.; Holodny, A.
International Journal of Radiation Oncology, Biology, Physics (2012)

Fulltext@MSK | Save

Ro4929097 in combination with radiotherapy and temozolomide for newly diagnosed malignant glioma (MG): A pharmacokinetic (Pk) and pharmacodynamic (Pd) study

Meeting Abstract

Omuro, A.; Beal, K.; Ivy, P.; Gutin, P.; Wu, N.; Kaley, T.; Karimi, S.; DeAngelis, L.; Pentsova, E.; Nolan, C.; more...
Neuro-Oncology (2012)

Fulltext@MSK | Save

Clinical implications of skeletal muscle blood-oxygenation-level-dependent (BOLD) MRI

Journal Article

Partovi, S.; Karimi, S.; Jacobi, B.; Schulte, A. C.; Aschwanden, M.; Zipp, L.; Lyo, J. K.; Karmonik, C.; Müller-Eschner, M.; Huegli, R. W.; more...
Magnetic Resonance Materials in Physics, Biology and Medicine (2012)

Fulltext@MSK | Save

Skeletal muscle BOLD MRI: From underlying physiological concepts to its usefulness in clinical conditions

Journal Article

Jacobi, B.; Bongartz, G.; Partovi, S.; Schulte, A. C.; Aschwanden, M.; Lumsden, A. B.; Davies, M. G.; Loebe, M.; Noon, G. P.; Karimi, S.; more...
Journal of Magnetic Resonance Imaging (2012)

Fulltext@MSK | Save

Effects of covert and overt paradigms in clinical language fMRI

Journal Article

Partovi, S.; Konrad, F.; Karimi, S.; Rengier, F.; Lyo, J. K.; Zipp, L.; Nennig, E.; Stippich, C.
Academic Radiology (2012)

Fulltext@MSK | Save

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases

Journal Article

Shukla-Dave, A.; Lee, N. Y.; Jansen, J. F. A.; Thaler, H. T.; Stambuk, H. E.; Fury, M. G.; Patel, S. G.; Moreira, A. L.; Sherman, E.; Karimi, S.; more...
International Journal of Radiation Oncology, Biology, Physics (2012)

Fulltext@MSK | Save

Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)

Meeting Abstract

Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)

Meeting Abstract

Grommes, C.; Karimi, S.; Beal, K.; Chan, T. A.; Abrey, L. E.; Gutin, P. H.; Omuro, A. M. P.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Longitudinal cognitive follow-up in newly diagnosed glioblastoma patients treated with bevacizumab, temozolomide and hypofractionated stereotactic radiotherapy

Meeting Abstract

Correa, D. D.; Baser, R.; Beal, K.; Karimi, S.; DeAngelis, L.; Panageas, K.; Barradas, R.; Statucka, M.; Abrey, L.; Gutin, P.; more...
Neuro-Oncology (2011)

Fulltext@MSK | Save